Advances in Immunotherapya. New treatments aim to modify the immune system to preserve insulin-producing cells.b. Examples include monoclonal antibodies and vaccines under research.

Artificial Pancreas Systemsa. Hybrid closed-loop insulin delivery devices automate insulin dosing.b. Benefits include improved blood sugar control and reduced hypoglycemia.

Stem Cell and Beta Cell Replacement Therapiesa. Experimental approaches use stem cells to regenerate insulin-producing cells.b. Clinical trials are ongoing, with challenges still being addressed.

Adjunctive Medicationsa. Newer drugs like SGLT2 inhibitors are being studied for type 1 diabetes.b. These may offer potential benefits but also carry risks.

Personalized Medicine and Continuous Monitoringa. Continuous glucose monitors (CGMs) and data-driven treatment plans enhance management.b. Technology is improving daily diabetes care.

Consultation with Specialistsa. Endocrinologists and diabetes care teams are crucial for managing new therapies.b. Discuss emerging treatments with healthcare providers for personalized advice.